Research use only · EU-warehoused · COA on every batch · HPLC ≥99% · Shipment 2–5 days
Log in Register
Research Journal

The science, examined.

Plain-spoken notes on the compounds we supply — what the literature shows, how to read a COA, and the protocols that protect your data. Cited, never hyped.

All Bioregulators Comparisons Guides Gut Hormonal Immune In the news Metabolic & longevity Methods & QC Nootropics Regulation Sexual health Skin & matrix Sleep Tissue repair
After Antibody-Drug Conjugates, Are Peptide-Drug Conjugates Next? In the news

After Antibody-Drug Conjugates, Are Peptide-Drug Conjugates Next?

TwoStep Therapeutics cleared an IND for TS-104, a peptide-drug conjugate delivering MMAE through an integrin-binding peptide, alongside a $62.5m Series A. What PDCs change…

Sep 2026 · 7 min read
Does Semaglutide Slow Ageing? What the New Nature Study Actually Shows Metabolic & longevity

Does Semaglutide Slow Ageing? What the New Nature Study Actually Shows

Semaglutide started at 20 months extended median lifespan in female mice from 742 to 834 days and beat matched calorie restriction on memory, exploration…

Sep 2026 · 7 min read
Research Use Only Is Not a Regulatory Shield: What the FDA’s 2026 Peptide Warning Letters Actually Say Regulation

Research Use Only Is Not a Regulatory Shield: What the FDA’s 2026 Peptide Warning Letters Actually Say

The FDA published five warning letters to research-peptide sellers on 1 September 2026. All five rest on website review alone, and the agency states…

Sep 2026 · 8 min read
Semaglutide in Children Aged 6 to 11: What the STEP Young Phase 3 Trial Actually Found In the news

Semaglutide in Children Aged 6 to 11: What the STEP Young Phase 3 Trial Actually Found

Novo Nordisk reported that 40.4% of children aged 6 to 11 fell below the obesity threshold on semaglutide against 0% on placebo. What that…

Sep 2026 · 9 min read
Is TFA Really an Inert Peptide Counterion? New Evidence Challenges a Long-Standing Assumption Methods & QC

Is TFA Really an Inert Peptide Counterion? New Evidence Challenges a Long-Standing Assumption

A September 2026 Nature Communications study reports that trifluoroacetate, the counterion on most synthetic peptides, binds PPAR-alpha and produces metabolic effects in mice, including…

Sep 2026 · 10 min read
BPC-157 Is Entering a Phase 1 Trial After Rotator Cuff Repair: What NCT07803250 Will Actually Test In the news

BPC-157 Is Entering a Phase 1 Trial After Rotator Cuff Repair: What NCT07803250 Will Actually Test

A Phase 1 study of BPC-157 after arthroscopic rotator cuff repair was posted to ClinicalTrials.gov on 3 September 2026. It is not the first…

Sep 2026 · 12 min read
The Solvent Problem: Peptide Manufacturing Is Scaling Into a Regulatory Squeeze Methods & QC

The Solvent Problem: Peptide Manufacturing Is Scaling Into a Regulatory Squeeze

GLP-1 demand pushed peptide synthesis to metric-ton scale. At the same moment the EU restricted DMF and added DMAc and NEP to Annex XVII.…

Aug 2026 · 5 min read
Why a Generic Peptide Is Harder Than a Generic Pill: Inside FDA’s July 2026 Guidance Revision Regulation

Why a Generic Peptide Is Harder Than a Generic Pill: Inside FDA’s July 2026 Guidance Revision

FDA revised 17 product-specific guidances for generic peptides and withdrew its 2021 synthetic peptide guidance. The five areas it targeted explain why the same…

Aug 2026 · 7 min read
Designed Peptides in August 2026: Three Papers, Three Different Meanings of “Designed” Methods & QC

Designed Peptides in August 2026: Three Papers, Three Different Meanings of “Designed”

In one month: computationally designed antimicrobial nanopores that work in mice, an engineered peptide nanopore that detects single α-synuclein species, and LLM-assisted design of…

Aug 2026 · 6 min read
Mimrylo (Rusfertide): The FDA Just Approved a Peptide That Mimics a Hormone Most People Have Never Heard Of In the news

Mimrylo (Rusfertide): The FDA Just Approved a Peptide That Mimics a Hormone Most People Have Never Heard Of

On 28 August 2026 FDA approved Mimrylo (rusfertide) for polycythemia vera — the first hepcidin-mimetic peptide medicine. The mechanism is iron restriction, and it…

Aug 2026 · 5 min read
Avexitide: The Peptide That Blocks the Receptor Ozempic Activates In the news

Avexitide: The Peptide That Blocks the Receptor Ozempic Activates

Avexitide is a GLP-1 receptor antagonist — the same target as semaglutide, the opposite direction. In August 2026 it cut severe hypoglycaemic events by…

Aug 2026 · 5 min read
The Hormone That Kept Turning Into Amyloid: Why Amylin Took Thirty Years to Become a Drug Methods & QC

The Hormone That Kept Turning Into Amyloid: Why Amylin Took Thirty Years to Become a Drug

Human amylin forms amyloid fibrils in the pancreas, which is why it was undruggable. Three proline substitutions borrowed from rat amylin fixed it. And…

Aug 2026 · 6 min read
Previous Page 2 of 17 Next

New research, in your inbox

Occasional, considered notes on the compounds and the literature. No noise.

Subscribe & earn 500 points